• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表现为浆液性卵巢癌的恶性腹膜间皮瘤PAX8免疫染色的诊断效用:两例单中心报告

The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases.

作者信息

Nakamura Kohei, Nakayama Kentaro, Nagaoka Risa, Nishisako Kiyoka, Ishikawa Masako, Katagiri Hiroshi, Ishibashi Tomoka, Sato Emi, Amano Chika, Kyo Satoru

机构信息

Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan.

Department of Organ Pathology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan.

出版信息

Oncol Lett. 2017 Jan;13(1):263-266. doi: 10.3892/ol.2016.5444. Epub 2016 Nov 30.

DOI:10.3892/ol.2016.5444
PMID:28123552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5244981/
Abstract

Malignant peritoneal mesotheliomas (MPMs) are rare and progressive tumors, which may present similarly to primary peritoneal carcinoma or ovarian carcinoma (OC). The current study reports two cases of MPM that initially presented with the features of OC, for which paired box 8 (PAX8) immunostaining was found to be useful for diagnosis. The two patients were women, aged 58 and 56 years, respectively. The primary presenting symptoms and clinical findings included prolonged abdominal pain, abdominal swelling and cough. The two cases were initially diagnosed as OC and were treated with primary debulking surgery. The patient in case 1 had no history of asbestos exposure, while the patient in case 2 did. Final diagnoses were determined based on histological and immunohistochemical results, which included negative PAX8 immunostaining, and which were consistent with MPM. The present cases demonstrated that PAX8 negativity may be a useful diagnostic biomarker for differentiating MPM from OC.

摘要

恶性腹膜间皮瘤(MPM)是罕见的进展性肿瘤,其表现可能与原发性腹膜癌或卵巢癌(OC)相似。本研究报告了两例最初表现为OC特征的MPM病例,发现配对盒8(PAX8)免疫染色对诊断有用。两名患者均为女性,年龄分别为58岁和56岁。主要的首发症状和临床发现包括持续性腹痛、腹部肿胀和咳嗽。这两例最初均被诊断为OC,并接受了初次肿瘤细胞减灭术。病例1的患者无石棉接触史,而病例2的患者有。最终诊断基于组织学和免疫组化结果确定,其中包括PAX8免疫染色阴性,且与MPM一致。本病例表明,PAX8阴性可能是区分MPM与OC的有用诊断生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/a58c2e64bfda/ol-13-01-0263-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/58f3e9ef7cfc/ol-13-01-0263-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/c75645572b87/ol-13-01-0263-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/a58c2e64bfda/ol-13-01-0263-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/58f3e9ef7cfc/ol-13-01-0263-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/c75645572b87/ol-13-01-0263-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e124/5244981/a58c2e64bfda/ol-13-01-0263-g02.jpg

相似文献

1
The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases.表现为浆液性卵巢癌的恶性腹膜间皮瘤PAX8免疫染色的诊断效用:两例单中心报告
Oncol Lett. 2017 Jan;13(1):263-266. doi: 10.3892/ol.2016.5444. Epub 2016 Nov 30.
2
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.PAX8 可可靠地区分卵巢浆液性肿瘤和恶性间皮瘤。
Am J Surg Pathol. 2010 May;34(5):627-35. doi: 10.1097/PAS.0b013e3181da7687.
3
rearranged malignant peritoneal mesothelioma-Presenting with bilateral extensive pelvic masses in a young woman: Mimicking low-grade serous ovarian carcinoma.重新排列的恶性腹膜间皮瘤-年轻女性双侧广泛盆腔肿块:模仿低级别浆液性卵巢癌。
Indian J Pathol Microbiol. 2023 Apr-Jun;66(2):392-395. doi: 10.4103/ijpm.ijpm_360_21.
4
Malignant peritoneal mesothelioma: clinicopathological characteristics of two cases.恶性腹膜间皮瘤:两例临床病理特征
Case Rep Surg. 2014;2014:748469. doi: 10.1155/2014/748469. Epub 2014 Mar 4.
5
Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.配对盒基因 8(PAX8)在液基细胞学和细针抽吸细胞学中的表达的应用:转移性卵巢浆液性癌的免疫组化研究。
Cancer Cytopathol. 2010 Oct 25;118(5):298-302. doi: 10.1002/cncy.20089.
6
Malignant Peritoneal Mesothelioma: A Case Report.恶性腹膜间皮瘤:一例报告
Cureus. 2023 Aug 3;15(8):e42902. doi: 10.7759/cureus.42902. eCollection 2023 Aug.
7
Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas.表现为卵巢肿块的恶性间皮瘤。9例报告,包括2例原发性卵巢间皮瘤。
Am J Surg Pathol. 1996 Sep;20(9):1067-80. doi: 10.1097/00000478-199609000-00004.
8
A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature.一例术前误诊为卵巢癌的间皮瘤病例及文献综述
Gynecol Oncol Rep. 2016 Apr 26;17:26-8. doi: 10.1016/j.gore.2016.04.003. eCollection 2016 Aug.
9
Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.BAP1表达缺失在腹膜和妇科浆液性腺癌中非常罕见,可用于与腹部间皮瘤的鉴别诊断。
Hum Pathol. 2016 May;51:9-15. doi: 10.1016/j.humpath.2015.12.012. Epub 2015 Dec 29.
10
The value of PAX8 and WT1 molecules in ovarian cancer diagnosis.PAX8和WT1分子在卵巢癌诊断中的价值。
Rom J Morphol Embryol. 2013;54(1):17-27.

引用本文的文献

1
Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.原发性卵巢间皮瘤:病例系列及电镜检查与文献复习
Cancers (Basel). 2021 May 10;13(9):2278. doi: 10.3390/cancers13092278.

本文引用的文献

1
[Introduction of WHO classification of tumours of female reproductive organs, fourth edition].[世界卫生组织女性生殖器官肿瘤分类第四版介绍]
Zhonghua Bing Li Xue Za Zhi. 2014 Oct;43(10):649-50.
2
Huge peritoneal malignant mesothelioma mimicking primary ovarian carcinoma.酷似原发性卵巢癌的巨大腹膜恶性间皮瘤。
J Med Assoc Thai. 2013 Jan;96(1):107-11.
3
Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas.PAX8、PAX2、claudin-4 和 h-caldesmon 免疫染色在鉴别腹膜上皮样间皮瘤与浆液性癌中的价值。
Mod Pathol. 2013 Apr;26(4):553-62. doi: 10.1038/modpathol.2012.200. Epub 2012 Nov 30.
4
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.PAX8 可可靠地区分卵巢浆液性肿瘤和恶性间皮瘤。
Am J Surg Pathol. 2010 May;34(5):627-35. doi: 10.1097/PAS.0b013e3181da7687.
5
Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.美国间皮瘤发病率的时间趋势及未来病例预测:基于 1973 年至 2005 年 SEER 数据的更新
Crit Rev Toxicol. 2009;39(7):576-88. doi: 10.1080/10408440903044928.
6
Malignant peritoneal mesothelioma as a rare cause of ascites: a case report.恶性腹膜间皮瘤作为腹水的罕见病因:一例报告
J Med Case Rep. 2008 Apr 25;2:121. doi: 10.1186/1752-1947-2-121.
7
Peritoneal mesothelioma: a review.腹膜间皮瘤:综述
MedGenMed. 2007 May 10;9(2):32.
8
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.PAX8在卵巢癌和输卵管内膜发育中的新作用。
Gynecol Oncol. 2007 Feb;104(2):331-7. doi: 10.1016/j.ygyno.2006.08.052. Epub 2006 Oct 24.
9
Results of treatment of 33 patients with peritoneal mesothelioma.33例腹膜间皮瘤患者的治疗结果。
Br J Surg. 2000 Nov;87(11):1587-93. doi: 10.1046/j.1365-2168.2000.01571.x.